Antihypertensive drug classes
Pro Research Analysisby 
Searched over 200M research papers
Major Antihypertensive Drug Classes: Types and Mechanisms
There are several main classes of antihypertensive drugs, each with distinct mechanisms of action. The five major classes are:
- Beta-blockers
- Diuretics
- Angiotensin-converting enzyme inhibitors (ACE inhibitors)
- Angiotensin II receptor blockers (ARBs)
- Calcium channel blockers (CCBs)
Other classes include renin inhibitors, alpha-adrenergic receptor blockers, centrally acting agents, and direct-acting vasodilators. These drugs work by targeting different molecular receptors and sites in the body to lower blood pressure, and their side effects are linked to their specific mechanisms of action. Understanding these differences helps guide the choice of drug for individual patients and specific types of hypertension Laurent2017Malani2025.
Efficacy of Antihypertensive Drug Classes for Cardiovascular and Stroke Prevention
ACE inhibitors, ARBs, and CCBs are consistently shown to reduce the risk of major cardiovascular events compared to placebo. Diuretics also show a similar trend, while beta-blockers and renin inhibitors are less effective in this regard. Among these, ARBs and CCBs are often preferred as first-line agents due to their favorable balance of efficacy and acceptability .
For stroke prevention, ACE inhibitors, ARBs, CCBs, and diuretics all outperform placebo. CCBs and diuretics are particularly effective in reducing stroke risk, with dihydropyridine CCBs and thiazide-like diuretics providing the most benefit. Combination therapy, especially ACE inhibitors plus CCBs, offers even greater protection against stroke and mortality than monotherapy .
Combination Therapy: Enhanced Outcomes
Combining antihypertensive drug classes is often more effective than using a single agent. The combination of renin-angiotensin system inhibitors (such as ACE inhibitors or ARBs) with CCBs is especially effective in preventing major cardiovascular events. Combinations that include ARBs tend to be more acceptable to patients, while those with ACE inhibitors may have higher rates of discontinuation due to side effects. The combination of ACE inhibitors and CCBs is also associated with reduced cardiovascular mortality, particularly in patients with type 2 diabetes Remonti2016Brunström2023.
Adherence and Acceptability of Antihypertensive Drug Classes
Patient adherence to antihypertensive medications varies by drug class. Adherence is generally highest with ARBs and ACE inhibitors, and lowest with diuretics and beta-blockers. However, overall adherence remains suboptimal across all classes. Acceptability, measured by rates of treatment discontinuation, is best with ARBs and CCBs, making them preferable choices for many patients Kronish2011Brunström2023.
Effects on Cognitive Decline and Other Health Outcomes
Antihypertensive treatment, regardless of class, has a positive effect on cognitive function and may reduce the risk of dementia. Among the classes, ARBs appear to offer the greatest cognitive benefits compared to beta-blockers, diuretics, and ACE inhibitors . ACE inhibitors and CCBs also show benefits for kidney and immune function, and CCBs are considered safe for use in pregnancy-related disorders .
Emerging and Novel Antihypertensive Drug Classes
New drug classes are being developed to target additional pathways involved in hypertension. These include dual angiotensin II receptor-neprilysin inhibitors, soluble guanylate cyclase stimulators, nonsteroidal mineralocorticoid receptor antagonists, and sodium-glucose cotransporter 2 inhibitors. Some of these are being developed for related conditions like heart failure and diabetic kidney disease, but may also benefit hypertension management in the future .
Conclusion
Antihypertensive drug classes differ in their mechanisms, efficacy, side effects, and patient acceptability. ACE inhibitors, ARBs, and CCBs are most effective for cardiovascular protection, with ARBs and CCBs offering the best balance of efficacy and tolerability. Combination therapies, especially those pairing ACE inhibitors or ARBs with CCBs, provide enhanced protection against cardiovascular events and stroke. New drug classes continue to emerge, offering hope for improved blood pressure control and broader health benefits.
Sources and full results
Most relevant research papers on this topic